Baxter
BAX
#1956
Rank
$10.61 B
Marketcap
$20.63
Share price
-2.96%
Change (1 day)
-40.15%
Change (1 year)

Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.

P/S ratio for Baxter (BAX)

P/S ratio at the end of 2025: 0.8915

According to Baxter's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.74. At the end of 2025 the company had a P/S ratio of 0.8915.

P/S ratio history for Baxter from 2001 to 2025

PS ratio at the end of each year

Year P/S ratio Change
20250.8915-36.4%
20241.40-25.96%
20231.89-25.9%
20222.55-27.8%
20213.540.78%
20203.51-5.74%
20193.7322.45%
20183.04-8.57%
20173.3340.22%
20162.3713.22%
20152.10-43.48%
20143.71-7.57%
20134.0153.57%
20122.6130.1%
20112.01-12.26%
20102.29-18.46%
20092.814.3%
20082.69-17.69%
20073.2712.46%
20062.9121.72%
20052.396.43%
20042.246.6%
20032.111.59%
20022.07-52.53%
20014.37

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Medtronic
MDT
3.57 270.78%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Thermo Fisher Scientific
TMO
4.43 360.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
3.03 214.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
5.76 498.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
5.99 521.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
0.2269-76.43%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
1.62 68.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
6.68 593.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Owens & Minor
OMI
0.0323-96.65%๐Ÿ‡บ๐Ÿ‡ธ USA
CryoLife
CRY
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA